A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
SirenWired
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

#SocPharm Tweetchat Transcript 4/4/2012

Posted by | 11:44pm on Wednesday, April 4, 2012

:
It’s time to grab your beer, wine or water & join in the #socpharm tweetchat. Rob Halper the man behind @: is moderating. #epharma

:
Disclaimer: we assume all #socpharm tweets reflect personal opinions & not that of your employer/clients & are not legal or medical advice!

:
Welcome to #socpharm, please say hello. I know @ just got home after a traffic jam filled commute!

:
Hello “@EileenOBrien: : Welcome to #socpharm, please say hello. I know @ just got home after a traffic jam filled commute!”

:
@: reminder that you need to put #socpharm in all your tweets for them to appear in the stream!

:
#socpharm RT @ views I will be expressing will be my own, and I’m not acting as a spokesperson for Johnson & Johnson of its…

:
For those of you who don’t know, I run the jnjhealth channel on you tube. http://t.co/YR6qPQJw #socpharm

:
Hi All – Looking forward to #socpharm conversation! Chuck #socpharm

:
My first time here at #socpharm thanks to @ for the heads up

:
@ The J&J YouTube channel hit a pretty impressive stat recently – is it 6 Million video views? #socpharm

:
@: nice, 6 million+ views! #socpharm

:
Any questions about #socpharm and the use of video/youtube?

:
@: Yes! And without any dogs playing the piano! #socpharm

:
Shire started a Facebook page called ADHD hub #socpharm

:
@ I know you have comments turned on. About how many comments do you get each month? #socpharm

:
@ It varies, but usually I get between 5-10 a day. They are pre-moderated, so I see them before they are posted. #socpharm

:
How long to premoderate at approve? #socpharm

:
@ Since channel started about how many videos have you posted? How many comments posted? How many NOT posted? #socpharm

:
@ I wasn’t aware of this FB page http://t.co/xohWts55 tx for sharing. LOTS of likes. Is wall closed? #socpharm

:
@ I’ve posted nearly 600 videos over the last 4 years. I’d say 80% of the comments get posted. #socpharm

:
I post anything that is reasonable and not insulting or profane, even if it doesn’t agree with our point of view #socpharm

:
@: you know it! #socpharm

:
@: yes wall is closed I think :( #socpharm

:
@ Thanks. we LOVE doing stories like that. They inspire me as well. #socpharm

:
@ I remember in the last chat you said that most comments you approve & only a few do you run by med/reg/legal for review. #socpharm

:
Who creates the video? @: : I’ve posted nearly 600 videos over the last 4 years 80% of the comments get posted #socpharm

:
Anyone know of any health apps that have successfully created a soc network as well? #socpharm

:
@ Looks like Shire FB page is way to get Vyvanse coupon.Clearly popular. as seen by Likes. #socpharm

:
@: We create them in house. I hire producers and they work with freelance crews and editors using our facilities.#socpharm

:
Hey #socpharm folks ~ Wendy Blackburn here, jumping in to learn and share

:
@: The exception to that is when we do shoots out of state, when I hire local video crews, but I’ll send a producer #socpharm

:
@ To what do you attribute the success of the YouTube channel? #socpharm

:
@: Do comments from viewers show a deeper level of engagment through video? #socpharm

:
Over 60k likes I think #socpharm

:
@ If there are comments which are potential AE’s I send to the appropriate legal depts, but there aren’t too many #socpharm

:
At a conference last week, @: YouTube was discussed often as best-in-class example. Well done #socpharm

:
How do you find/select stories for video? MT @: : I’ve posted nearly 600 videos over 4 years. 80% comments posted #socpharm

:
@: You mean as compared to other platforms? In my experience, yes. But I guess it depends upon what you’re measuring #socpharm

:
@ That’s always nice to hear. Thank you! #socpharm

:
@: Some of the videos have hundreds of comments, one has about 1200. #socpharm

:
@: Several different ways, but I mostly rely on my judgement. We want to cover all relevant health topics #socpharm

:
@: That’s amazing! What was the topic? #socpharm

:
@: And I’m cognizant of health days. This month is National Autism Awareness. So that’s what I’m featuring #socpharm

:
@: how are folks using Pintrest? #socpharm

:
@ I’m not sure yet! It’s in that middle ground between professional and personal – Profersonal?! #socpharm

:
@: What’s been your biggest learning throughout the project? #socpharm

:
@: just learned that @ is on Pintrest #socpharm

:
@ So we’ll post infographics, relevant cartoons, and I post videos from jnjhealth But also scenes from Mad Men! #socpharm

:
@ Interesting! Have to check it out. #socpharm

:
@ Did I hear that J&J recently started using Pinterest? I know a few others are experimenting. #socpharm

:
@ I’m pleasantly surprised about how much interest there is in healthcare info, and the hunger for it. #socpharm

:
@ We’re just playing with it, not officially using it. #socpharm

:
@: It was the first video I posted, which explains part of it. Teenage Obesity and Weight Loss Surgery #socpharm

:
@: Interesting! That’s good to hear. Glad you are meeting the need. #socpharm

:
Novo Nordisk reserved their Pinterest name but hasn’t done anything. There is no way to moderate comments so makes it tough #socpharm

:
@: What criteria will you use to determine if/when to officially jump in? #socpharm

:
Hi all #socpharm ers. Frieda Hernandez from Siren joining late :-( Looks like a great convo.

:
Anyone else have copyright concerns re Pinterest? Or are companies just using images which they own rights? #socpharm

:
@: In relation to pinterest? I guess when we feel it has enough traction to justify our being in that space. #socpharm

:
@: We are watching it but liken it to early days of Facebook and YouTube (similar concerns). #socpharm

:
RT @: @: just learned that @ is on Pintrest #socpharm

:
I know @ can’t talk specifics, but hot topic last week was Psoriasis360 closing FB page. Can/should pharma have FB pages? #socpharm

:
@: : Do you actively seek to have your videos linked to news stories or other blogs or tweeted about? #socpharm

:
@: great question. #socpharm

:
@ I can’t speak for our pharma cos. but barrier is not being able to monitor comments – a regulatory/resource concern #socpharm

:
@: Regarding Facebook/pharma, IMHO,”It depends.” On objectives, disease, audience, blackbox status, bandwidth etc #socpharm

:
@: I do some promotion within the you tube community, but I generally don’t publicize them otherwise. #socpharm

:
@: However, sometimes our operating companies include the video in a multimedia press release eg. HIV/AIDS #socpharm

:
W/FB filtering tool&ongoing moderation comments can b monitored. In #raredisease space we find pharma brings value/plays imp role #socpharm

:
Agree! RT @: Re Facebook/pharma, IMHO,”It depends.” On objectives, disease, audience, blackbox status, bandwidth #socpharm

:
@: Love to hear that patients want pharma to participate in social media. That is often a question #socpharm

:
@ Yes, those amazing #raredisease patients/caregivers want treatments, cure, info, support & more from pharma. #socpharm

:
Gotta run – thx for letting me jump in/out and @: thx for sharing your wisdom! @: great job as usual! #socpharm

:
@: : how do you measure ROI? Views? Comments? Is that quantifying engagement or return? BTW thanx a ton for ur responses #socpharm

:
@ My pleasure. Thanks! #socpharm

:
Firms that have access to #EHR Gould also be engaging #socpharm

:
#socpharm RT @: : Agree w/@WendyBlackburn: FB is the most problematic social media for pharma. Reminds us that sm is a tactic to su

:
Agree w/@wendyblackburn @: I think FB is the most problematic social media for pharma… #socpharm

:
@: Great questions! Ah.. ROI, Return on Ignoring..I measure by views and “engagements”, but don’t see how to quantify #socpharm

:
…FB reminds us that soc med is a tactic that must support overall strategy #socpharm

:
@: Great way to repurpose & encourage additional exposure thru traditional media coverage. #socpharm

:
@: a place where folks still seem 2 get a bit tripped up SM is a tactic not strategy, do if it makes sense not just b/c #socpharm

:
@: Yes. I think you raise a good point. They should be more synergistic. #socpharm

:
@: Right & FB requires new content creation. Like a YouTube channel. It was gr8 J&J decided to dedicate resources. #socpharm

:
@ Everyone pretty much tired out? :-) #socpharm

:
@: Absolutely agree! Objectives for FB page must tie back to overall strategic goals. #socpharm

:
RT @: : @: Absolutely agree! Objectives for FB page must tie back to overall strategic goals. #socpharm

:
@ I think so, and the hour is up! Thanks so much for answering all our questions #socpharm

:
Mark your calendars for May 2 the next #socpharm chat when @ from @ will be moderating.

:
@: and @: Thanks for a great #socpharm convo.

:
@ Great questions. Thanks, everyone. #socpharm

:
@ Thanks again for doing such a great job moderating. I’ll post a link to the transcript tomorrow. #socpharm

:
@ Thanks, Eileen. Have a good night. #socpharm

About Eileen O'Brien

Eileen has more than 16 years of digital healthcare marketing experience. She is an opinion leader on social media and biopharma, and has been invited to speak at industry conferences and quoted in publications.

View other posts from Eileen

7 Pingbacks/Trackbacks

    05 April 2012 at 4:04pm
    Transcript from last night's ...
  • Eileen O'Brien
  • 05 April 2012 at 4:04pm
    RT @EileenOBrien Transcript from ...
  • soulful sepulcher
  • 05 April 2012 at 4:04pm
    Transcript from last night's ...
  • MedCom Solutions
  • 05 April 2012 at 5:04pm
    Thx for sharing, Eileen! RT ...
  • Casey Ferrell
  • 05 April 2012 at 7:04pm
    RT @eileenobrien: Transcript from ...
  • JNJVideo
  • 05 April 2012 at 7:04pm
    @eileenobrien Enjoyed the Tweetchat ...
  • JNJVideo
  • 05 April 2012 at 7:04pm
    @eileenobrien Enjoyed the Tweetchat ...
  • rhalper
Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com